
Acorda Therapeutics ACOR
Land |
|
IPO-Jahr |
2006 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
1.24 M |
Marktkapitalisierung |
$ 820 K |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Certara
CERT
|
$ 10.56 | -1.12 % | $ 1.69 B | Nasdaq Global Select Market | ||
|
Intec Pharma Ltd
NTEC
|
- | -12.45 % | $ 17.7 M | Nasdaq Capital Market | ||
|
Anika Therapeutics
ANIK
|
$ 13.26 | -0.15 % | $ 190 M | Nasdaq Global Select Market,SPB | ||
|
Aprea Therapeutics
APRE
|
$ 0.23 | -52.81 % | $ 1.5 M | Nasdaq Global Select Market,SPB | ||
|
Galectin Therapeutics
GALT
|
$ 2.68 | -4.63 % | $ 171 M | Nasdaq Global Select Market | ||
|
Processa Pharmaceuticals
PCSA
|
$ 1.59 | -5.92 % | $ 2.08 M | Nasdaq Global Select Market | ||
|
Corcept Therapeutics Incorporated
CORT
|
$ 63.61 | -2.11 % | $ 6.61 B | Nasdaq Capital Market,SPB | ||
|
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | ||
|
Genprex
GNPX
|
$ 1.46 | -12.87 % | $ 1.36 M | Nasdaq Capital Market | ||
|
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | ||
|
Nektar Therapeutics
NKTR
|
$ 30.23 | -7.1 % | $ 510 M | Nasdaq Global Select Market,SPB | ||
|
Innate Pharma S.A.
IPHA
|
$ 0.87 | -7.57 % | $ 77.9 M | Nasdaq Global Select Market | ||
|
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | ||
|
BioMarin Pharmaceutical
BMRN
|
$ 60.42 | -1.64 % | $ 11.6 B | Nasdaq Global Select Market,SPB | ||
|
Matinas BioPharma Holdings
MTNB
|
$ 0.75 | -9.23 % | $ 4.11 M | NYSE American | ||
|
Enanta Pharmaceuticals
ENTA
|
$ 7.6 | -4.82 % | $ 220 M | Nasdaq Global Select Market,SPB | ||
|
Milestone Pharmaceuticals
MIST
|
$ 0.38 | -5.66 % | $ 40.4 M | Nasdaq Global Select Market | ||
|
Lipocine
LPCN
|
$ 1.47 | -2.33 % | $ 8.01 M | Nasdaq Global Select Market | ||
|
Seres Therapeutics
MCRB
|
$ 1.25 | -6.02 % | $ 11.1 M | Nasdaq Global Select Market | ||
|
Oramed Pharmaceuticals
ORMP
|
$ 3.58 | -2.98 % | $ 148 M | Nasdaq Global Select Market | ||
|
Madrigal Pharmaceuticals
MDGL
|
$ 378.19 | -4.68 % | $ 8.48 B | Nasdaq Global Select Market,SPB | ||
|
CEL-SCI Corporation
CVM
|
$ 1.2 | -18.37 % | $ 9.62 M | NYSE American,SPB | ||
|
Inventiva S.A.
IVA
|
$ 3.14 | -9.13 % | $ 188 M | Nasdaq Global Market | ||
|
MeiraGTx Holdings plc
MGTX
|
$ 7.98 | -1.97 % | $ 642 M | Nasdaq Global Select Market | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
$ 39.21 | 1.76 % | $ 44.9 B | NYSE | ||
|
Eton Pharmaceuticals
ETON
|
$ 60.77 | -0.96 % | $ 1.64 B | Nasdaq Global Market | ||
|
IDEAYA Biosciences
IDYA
|
$ 25.52 | -2.48 % | $ 2.26 B | Nasdaq Global Select Market | ||
|
Protalix BioTherapeutics
PLX
|
$ 2.89 | -5.56 % | $ 227 M | NYSE American | ||
|
Lantern Pharma
LTRN
|
$ 0.25 | -13.67 % | $ 2.72 M | Nasdaq Global Select Market | ||
|
Foghorn Therapeutics
FHTX
|
$ 1.71 | -3.93 % | $ 108 M | Nasdaq Global Market | ||
|
Ocugen
OCGN
|
$ 0.77 | 4.74 % | $ 241 M | Nasdaq Capital Market | ||
|
Oncolytics Biotech
ONCY
|
$ 0.35 | -10.37 % | $ 33.6 M | Nasdaq Global Select Market | ||
|
Minerva Neurosciences
NERV
|
$ 2.03 | -4.25 % | $ 17.2 M | Nasdaq Global Market | ||
|
Neurocrine Biosciences
NBIX
|
$ 150.5 | -3.89 % | $ 15 B | Nasdaq Global Select Market,SPB | ||
|
Nanobiotix S.A.
NBTX
|
$ 26.12 | -1.7 % | $ 1.25 T | Nasdaq Global Select Market | ||
|
Prothena Corporation plc
PRTA
|
$ 8.12 | -3.33 % | $ 437 M | Nasdaq Global Select Market,SPB | ||
|
Mereo BioPharma Group plc
MREO
|
$ 0.26 | -5.45 % | $ 207 M | Nasdaq Global Select Market | ||
|
Maravai LifeSciences Holdings
MRVI
|
$ 6.99 | -2.85 % | $ 1.01 B | Nasdaq Global Select Market | ||
|
Lexicon Pharmaceuticals
LXRX
|
$ 1.53 | -8.68 % | $ 555 M | Nasdaq Global Select Market | ||
|
Moleculin Biotech
MBRX
|
$ 7.73 | -2.59 % | $ 9.16 M | Nasdaq Global Select Market | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
$ 21.79 | 1.66 % | $ 34.4 B | NYSE | ||
|
Nurix Therapeutics
NRIX
|
$ 12.88 | -5.29 % | $ 1.12 B | Nasdaq Global Select Market,SPB | ||
|
Nkarta
NKTX
|
$ 1.14 | 1.34 % | $ 84.3 M | Nasdaq Global Select Market | ||
|
MacroGenics
MGNX
|
$ 1.97 | -0.76 % | $ 124 M | Nasdaq Global Select Market | ||
|
Protagonist Therapeutics
PTGX
|
$ 121.72 | -2.2 % | $ 7.74 B | Nasdaq Global Select Market | ||
|
Novo Nordisk A/S
NVO
|
$ 37.8 | -2.82 % | $ 168 B | NYSE | ||
|
Marker Therapeutics
MRKR
|
$ 1.1 | -17.05 % | $ 16.8 M | Nasdaq Global Market | ||
|
Arcus Biosciences
RCUS
|
$ 15.62 | -1.01 % | $ 1.68 B | NYSE,SPB | ||
|
Replimune Group
REPL
|
$ 19.07 | -0.83 % | $ 1.77 B | Nasdaq Global Select Market | ||
|
NextCure
NXTC
|
$ 6.62 | -2.43 % | $ 35.2 M | Nasdaq Global Select Market |